Related Experiment Videos
Influence of mitotane on the hypoprothrombinemic effect of warfarin
Abstract:
Mitotane (o,p'-DDD) is closely related to the organochlorine insecticides and shares their effects on drug metabolism. We have reported the first documented interaction of mitotane and warfarin in a human being. Because the potential for significant toxicity is great when mitotane and warfarin are used concomitantly, caution is recommended when titrating warfarin therapy in patients receiving mitotane. Other drugs susceptible to the influence of enzyme inducers should also be given with caution to patients receiving mitotane.
Insights
Mitotane, an organochlorine compound, interacts with warfarin, increasing toxicity risks. Careful warfarin dose adjustments are crucial for patients on mitotane therapy.
Area of Science:
- Pharmacology
- Drug Metabolism
- Toxicology
Background:
- Mitotane (o,p'-DDD) is structurally similar to organochlorine insecticides.
- Organochlorines are known to affect drug metabolism pathways.
- Warfarin is a commonly prescribed anticoagulant with a narrow therapeutic index.
Observation:
- The first documented human interaction between mitotane and warfarin is reported.
- Concomitant use of mitotane and warfarin presents a significant potential for toxicity.
Findings:
- Mitotane influences drug metabolism, similar to other organochlorine compounds.
- This interaction necessitates caution when managing warfarin therapy in patients receiving mitotane.
Implications:
- Healthcare providers should exercise extreme caution when titrating warfarin in patients concurrently treated with mitotane.
- Other medications metabolized by enzyme inducers may also require careful monitoring when co-administered with mitotane.